The Michigan Quality Improvement Consortium will establish and implement a core set of clinical practice guidelines and performance measures. The interventions designed and implemented by each plan to improve consistent delivery of services will be at the discretion of individual plans, but guidelines, performance goals, measurement methodology, and performance reporting will be standardized.
Antibiotics are the proper course of treatment for bacterial infections. However, these drugs are often administered for viral infections such as colds, sore throats, bronchitis, and some ear infections. When antibiotics are inappropriately administered, patients may develop a resistance to treatment, and this could negatively impact them when antibiotics are an appropriate treatment. The overuse of antibiotics also leads to the creation of antibiotic resistant bacteria that are no longer cured by treatment, which is a public health threat. The CDC estimates in the United States more than 23,000 individuals die each year from antibiotic resistant infections, and at least 2 million people are sickened from antibiotic resistant infections each year.
Antibiotics are drugs that are generally safe and used to fight disease, but there are times when antibiotics can negatively impact those using them. In fact, antibiotics are responsible for almost one-fifth of all emergency department visits due to adverse drug reactions, and they are the most common cause of ED visits for children under the age of 18. Adverse reactions include allergic reactions, diarrhea symptoms associated with antibiotics, and drug interactions/side effects.
In April 2014, the WHO declared that the antibiotic resistance problem “threatens the achievements of modern medicine. A post-antibiotic era — in which common infections and minor injuries can kill — is a very real possibility for the 21st century.” Now that we’re in the 21st century, going backwards is not where we want to go. There’s not much in the way of competition for developing these drugs, though some drug developers are finally getting back in the game.
Proper prescribing, educating patients and development of new drugs is vital to turning this around.
MQIC has released the following updated guidelines and guideline update alerts:
Adults with Systolic Heart Failure
MQIC guidelines assist by providing evidence-based recommendations in order for you to be able to focus on your patients. To help your patients increase their knowledge and commitment in their overall health, feel free to pass along MQIC guidelines and refer them to the website at www.mqic.org.
To sign-up to receive MQIC website updates, please Join Now.
For information about MQIC, you may Contact Us at anytime.
About Our Committee
The Michigan Quality Improvement Consortium establishes and implements clinical practice guidelines and performance measures with a focus on improvement for effecting positive health outcomes.
Medical Directors' Committee
- Develop common evidence-based clinical practice guidelines
- Provide direction and final decisions for MQIC
- Establish common definitions of populations among all health plans
- Establish common measurement protocols consistent with MQIC guidelines
- Coordinate MQIC communications
- Coordinate health plan and physician activities that complement MQIC quality improvement efforts
MQIC membership is diverse and includes physicians, health plan administrators, researchers, quality improvement experts, and specialty societies. The consortium recognizes the need to collaborate with other entities and experts to successfully achieve the consortium's vision.
Organizations and Health Plans